Carlyle Group Inc. PHAT Holdings History
Carlyle Group Inc.'s Phathom Pharmaceuticals Inc Holding Summary
As of 2025-03-31, Carlyle Group Inc. held 3.50 Mil shares of Phathom Pharmaceuticals Inc(PHAT), totaling $21.92 Mil. This investment constitutes 0.58% of their stock portfolio, and Carlyle Group Inc. now holds 5.01% of the outstanding Phathom Pharmaceuticals Inc(PHAT) stock.
The initial trade took place in 2023Q1. And since then Carlyle Group Inc. has made 2 purchases of PHAT, at an average price of $9.21, for a total of 3.50 Mil shares. Based on historical transaction data and PHAT's current price of $9.37, Carlyle Group Inc.'s estimated gain on his PHAT holdings is $557,755.36, reflecting a 1.73% gain to date.
Carlyle Group Inc. PHAT ($9.37) Holding Chart
Carlyle Group Inc. PHAT ($9.37) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
